Security
Canton Strategic Holdings, Inc. Common Stock · CNTN
CNTNNASDAQCommon stockCurrentCIK 1861657Updated Oct 30, 2026
Name history
Tharimmune, Inc. · through Feb 11, 2026Hillstream BioPharma Inc. · through Sep 12, 2023
CNTN price & chart
Loading TradingView…
NASDAQ:CNTN on TradingView ↗About the company
Tharimmune is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in immunology, inflammation and oncology. Its lead clinical asset, TH104, is being developed for a specific indication via a 505(b)2 pathway for respiratory and/or nervous system depression in military personnel and chemical incident responders who may encounter environments contaminated with high-potency opioids. The expanded pipeline includes other indications for TH104, such as chronic pruritus in primary biliary cholangitis and TH023, a new approach to treating autoimmune diseases along with an early-stage multispecific biologic platform targeting unique epitopes against multiple solid tumors through its proprietary EpiClick™Technology. The Company has a license agreement with OmniAb, Inc. to access their antibody discovery technology for targeting specified disease markers. Tharimmune continues to position itself as a leader in patient-centered innovation while working to deliver long-term value for shareholders. For more information, visit: www.tharimmune.com.
In the news
Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results ↗
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
4 filing
4 filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 7,699,378Source | 5,251,246Source | 564,570,386Source | 2,530,166Source | 8,257,447Source | 584,654,613Source | 1,661,294Source | 8,887,297Source | 519,146,435Source | 3,721,624Source | 10,946,393Source | 12,091,143Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,610,340Source | 4,774,237Source | 37,241,568Source | 2,241,980Source | 7,895,827Source | — | — | 8,427,290Source | — | — | 10,935,352Source | — |
| Assets, CurrentUSD | 7,699,378Source | 5,251,246Source | 41,216,634Source | 2,530,166Source | 8,257,447Source | 43,085,250Source | 1,661,294Source | 8,887,297Source | 17,386,066Source | 3,721,624Source | 10,946,393Source | 12,091,143Source |
| Prepaid Expense and Other Assets, CurrentUSD | 89,038Source | 477,009Source | 3,274,069Source | 196,018Source | 301,620Source | 1,553,110Source | 468,366Source | 460,007Source | 353,318Source | 45,263Source | 11,041Source | 969,289Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,544,551Source | 2,233,697Source | 109,667,774Source | 2,162,807Source | 1,563,539Source | 114,855,295Source | 2,475,965Source | 1,837,890Source | 121,220,555Source | 2,413,982Source | 1,815,046Source | 1,752,449Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 721Source | 129Source | 7,727Source | 422Source | 111Source | 5,665Source | 211Source | 1,180Source | 3,711Source | 198Source | 1,175Source | 1,136Source |
| Additional Paid in CapitalUSD | 49,623,860Source | 36,167,929Source | 594,380,217Source | 41,734,853Source | 36,048,454Source | 590,024,159Source | 38,697,881Source | 34,077,827Source | 470,809,478Source | 38,278,503Source | 33,903,663Source | 20,191,212Source |
| Retained Earnings (Accumulated Deficit)USD | -43,399,789Source | -33,080,544Source | -139,415,367Source | -41,297,951Source | -29,284,692Source | -120,160,541Source | -39,442,798Source | -26,959,635Source | -72,817,344Source | -36,901,094Source | -24,703,526Source | -9,853,654Source |
| Stockholders' Equity Attributable to ParentUSD | 6,154,827Source | 3,017,549Source | 454,902,612Source | 367,359Source | 6,693,908Source | 469,799,318Source | -814,671Source | 7,049,407Source | 397,925,880Source | 1,307,642Source | 9,131,347Source | 10,338,694Source |
| Liabilities and EquityUSD | 7,699,378Source | 5,251,246Source | 564,570,386Source | 2,530,166Source | 8,257,447Source | 584,654,613Source | 1,661,294Source | 8,887,297Source | 519,146,435Source | 3,721,624Source | 10,946,393Source | 12,091,143Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,544,551Source | 2,233,697Source | 2,625,998Source | 2,162,807Source | 1,563,539Source | 1,141,344Source | 2,475,965Source | 1,837,890Source | 3,286,364Source | 2,413,982Source | 1,815,046Source | 1,752,449Source |
| Accounts Payable, CurrentUSD | 659,254Source | 783,839Source | 916,244Source | 770,610Source | 784,029Source | 402,311Source | 838,184Source | 993,244Source | 1,090,274Source | 1,089,666Source | 908,577Source | 597,455Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | 107,041,776Source | — | — | 113,713,951Source | — | — | 117,934,191Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 689,804Source | 1,369,090Source | 983,715Source | 1,057,941Source | 579,462Source | 739,033Source | 1,117,728Source | — | 2,196,090Source | 1,324,316Source | — | 218,885Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 117,934,191Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 32,259,757Source | 219,179Source | 2,877,856Source | — | 831,862Source | 800,696Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -7,635,188Source | -2,689,001Source | -16,128,316Source | -10,901,991Source | -7,300,106Source | -6,557,950Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -54,822,298Source | — | -77,572,567Source | — | — | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 86,956,878Source | 205,568Source | 107,174,270Source | 3,526,000Source | 11,724,924Source | 13,064,128Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 24,499,392Source | -2,483,433Source | 13,473,387Source | -7,375,991Source | 4,424,818Source | 6,506,178Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 7,610,340Source | 4,774,237Source | 37,241,568Source | 2,241,980Source | 41,532,140Source | 1,075,928Source | 17,032,748Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 8,471Source | 28,345Source | 13,684Source | 16,505Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 527,014Source | 191,943Source | — | 567,636Source | 32,259,757Source | 219,179Source | 2,886,109Source | 710,313Source | 831,862Source | 800,696Source |
| General and Administrative ExpenseUSD | — | — | 1,815,775Source | 1,583,744Source | 2,698,013Source | 1,304,956Source | 36,600,488Source | 1,952,599Source | 17,032,102Source | 6,041,695Source | 5,895,585Source | 4,603,514Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | -6,672,175Source | — | -4,220,240Source | — | -6,187,113Source | — | 0Source | — |
| InterestExpenseNonoperatingUSD | — | — | 9,648Source | 3,009Source | — | 6,161Source | — | 8,471Source | 28,345Source | 13,684Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,101,838Source | -3,795,852Source | -19,254,826Source | -1,855,153Source | -47,343,197Source | -2,541,704Source | -35,916,250Source | -12,197,568Source | -9,319,094Source | -8,473,182Source |
| Nonoperating Income (Expense)USD | — | — | -8,260Source | 69,719Source | -23,424,102Source | -3,993Source | -14,695,126Source | 4,965Source | -21,997,297Source | 236,224Source | 136,126Source | -1,591,244Source |
| Operating ExpensesUSD | — | — | 2,093,578Source | 3,865,571Source | 2,698,013Source | 1,428,594Source | 36,868,311Source | 2,546,669Source | 20,106,066Source | 12,433,792Source | 9,455,220Source | 6,881,938Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | 3,558,441Source | — | 9,981,802Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 99,368,636Source | — | 12,234,929Source | 13,645,643Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 166,250Source | — | — | 24,389Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -2,093,578Source | -3,865,571Source | -1,202,154Source | -1,428,594Source | -36,868,311Source | -2,546,669Source | -20,106,066Source | -12,433,792Source | -9,455,220Source | -6,881,938Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | -24,626,256Source | -1,432,587Source | -51,563,437Source | -2,541,704Source | -42,103,363Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | -6,672,175Source | — | -4,220,240Source | — | -6,187,113Source | — | 0Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,101,838Source | -3,795,852Source | -19,254,826Source | -1,855,153Source | -47,343,197Source | -2,541,704Source | -35,916,250Source | -12,197,568Source | -9,319,094Source | -8,473,182Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.34Source | -2.45Source | — | -0.64Source | -0.23Source | -0.99Source | -1.12Source | -9.41Source | -7.14Source | -0.75Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.34Source | -2.45Source | — | -0.64Source | -0.23Source | -0.99Source | -1.12Source | -9.41Source | -7.14Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 6,241,909Source | 1,547,324Source | 216,864,938Source | 2,877,327Source | 207,705,905Source | 2,572,715Source | 32,049,310Source | 1,296,290Source | 1,305,437Source | 11,316,804Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 6,241,909Source | 1,547,324Source | 216,864,938Source | 2,877,327Source | 207,705,905Source | 2,572,715Source | 32,049,310Source | 1,296,290Source | 1,305,437Source | — |
| Interest Expense (non-operating)USD | — | — | 9,648Source | 3,009Source | — | 6,161Source | — | 8,471Source | 28,345Source | 13,684Source | — | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 1,815,775Source | 1,583,744Source | 2,698,013Source | 1,304,956Source | 36,600,488Source | 1,952,599Source | 17,032,102Source | 6,041,695Source | 5,895,585Source | 4,603,514Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -42,103,363Source | — | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 16,505Source | 1,591,244Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 1,600,000Source |
| Interest Income, OtherUSD | — | — | 1,388Source | 72,728Source | 311,848Source | 2,168Source | 318,178Source | 13,436Source | 41,410Source | 249,908Source | 152,631Source | — |
| Nonoperating Income (Expense)USD | — | — | -8,260Source | 69,719Source | -23,424,102Source | -3,993Source | -14,695,126Source | 4,965Source | -21,997,297Source | 236,224Source | 136,126Source | -1,591,244Source |
| Operating ExpensesUSD | — | — | 2,093,578Source | 3,865,571Source | 2,698,013Source | 1,428,594Source | 36,868,311Source | 2,546,669Source | 20,106,066Source | 12,433,792Source | 9,455,220Source | 6,881,938Source |
| Research and Development ExpenseUSD | — | — | 277,803Source | 2,281,827Source | — | 123,638Source | 267,823Source | 594,070Source | 3,073,964Source | 6,392,097Source | 3,559,635Source | 2,278,424Source |
| Total Revenue | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-292648
Filing attachments
ex99-1.htm · 8-K · 2026-10-29
Exhibit 99.1 Canton Strategic Holdings Announces Intent to Become First Tokenized U.S. Equity Announcement Follows SEC’s Innovation Exemption, Paving the Way for Compliant Onshore Access, 24/7 Trading, and Atomic Settlement of Tokenized Equities Tokenized Shares Issued by Onchain Transfer Agent Fairmint and Traded on TSV LLC via the Tradecraft Protocol Would Carry the Same Rights as Nasdaq Shares of CNTN, With 24/7 Trading and Atomic Settlement on the Canton Network NEW YORK, October 29, 202…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-14
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results Records first operating revenue from locking service and Super Validator operations Completes sale of legacy biotechnology subsidiary Gravitas NEW YORK, August 14, 2026 - Canton Strategic Holdings, Inc. (Nasdaq: CNTN) (“Canton Strategic” or the “Company”), the first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s a…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-23
EX-99.1 5 ex99-1.htm EX-99.1 Exhibit 99.1 CANTON STRATEGIC HOLDINGS, INC. UNAUDITED PRO FORMA CONSOLIDATED CONDENSED FINANCIAL INFORMATION Introduction On July 17, 2026, Canton Strategic Holdings, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with Gravitas Collective Corp., a Delaware corporation (“ Buyer ”), pursuant to which the Company agreed to sell, and Buyer agreed to purchase, all of the issued and outstanding membership interests…
Read attachment ↗ex99-2.htm · 8-K · 2026-07-23
EX-99.2 6 ex99-2.htm EX-99.2 Exhibit 99.2 Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC. Transaction Drives Greater Focus on Company’s Canton Network Strategy NEW YORK, July 23, 2026 - Canton Strategic Holdings, Inc., (NASDAQ: CNTN) (“Canton Strategic Holdings” or the “Company”) the first publicly traded company to leverage Canton Coin to support the Canton Network’s ability to digitize traditional financial markets, today announced the sale of its biotech …
Read attachment ↗ex99-1.htm · 8-K · 2026-06-16
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Canton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Program NEW YORK, June 16, 2026 - Canton Strategic Holdings, Inc., (NASDAQ: CNTN) (“Canton Strategic Holdings” or the “Company”) the first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s ability to digitize traditional financial markets, today announced today announced that its Board of Directors (the “Board”) has authorized a share re…
Read attachment ↗ex99-1.htm · 8-K · 2026-03-31
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results First Annual Report Since Establishing Canton Network Digital Asset Strategy Highlights Accelerating Network Momentum and Strengthened Capital Position NEW YORK, March 31, 2026 - Canton Strategic Holdings, Inc. (NASDAQ: CNTN) (“Canton Strategic Holdings” or the “Company”), the first publicly traded company to leverage Canton Coin (CC) to support the Canton Network’s…
Read attachment ↗